KR850000467A - 약학적 유용 펩티드의 제조방법 - Google Patents

약학적 유용 펩티드의 제조방법 Download PDF

Info

Publication number
KR850000467A
KR850000467A KR1019840002863A KR840002863A KR850000467A KR 850000467 A KR850000467 A KR 850000467A KR 1019840002863 A KR1019840002863 A KR 1019840002863A KR 840002863 A KR840002863 A KR 840002863A KR 850000467 A KR850000467 A KR 850000467A
Authority
KR
South Korea
Prior art keywords
hydrogen
peptide
general formula
same
process according
Prior art date
Application number
KR1019840002863A
Other languages
English (en)
Inventor
윌리암 하아디 조오지 (외 2)
Original Assignee
미첼 피터 잭슨
더 웰컴 파운데이숀 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미첼 피터 잭슨, 더 웰컴 파운데이숀 리미티드 filed Critical 미첼 피터 잭슨
Publication of KR850000467A publication Critical patent/KR850000467A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

내용 없음.

Description

약학적 유용 펩티드의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 시제(II)와 시제(III)을 반응시키는 것과 반응 C-말단 펩티드 카르복실산 또는 그것의 적합한 반응 유도체를 아미드화 시키는 것과 1-아미디노-3,5-디메틸피라졸 또는 화학적으로 상등한 시제를 사용하여 X2가 하기의 D-라디칼인 상응 펩티드를 아미드화시키는 것과 그 생산물을 유기펩티드 또는 그것의 염으로 적합하게 전환시키는 것을 특징으로하는 하기 일반식(I)펩티드 또는 그것의 염을 제조하는 방법.
    일반식(I)에서 R'은 수소, 1 또는 2탄소원자의 알킬 또는 페아미디노기, R2는 1 또는 2탄소원자의 알킬, R3는 수소 또는 카바밀, X2는 하기 구조의 D-라디칼
    Z1과 Z2는 동일 또는 다르게 각각 수소, 할로, 니트로, 또는 트리플루오로메틸이며 최소한 하나는 수소 이외의 것이다. m은 2,3 또는 4, n이 0,1 또는 2며 R3가 카바밀일때 n은 항상 1이다. 일반식(II)에서 R1은 일반식(I)에서와 같으며 Y1은 일반식(I)에서의 상응 N-말단부분의 라디칼서열과 동일하며, 일반식(III)에서 Y2는 상기 정의된 생산 펩티드의 남은 부분과 동일하며 그것의 상융 C-말단부분 라디칼 서열을 포함하며, 시제(II)와(III)은 적당한 곳에서 임의적으로 보호 및 또는 활성화되고 적절하게 생산물의 탈보호가 수행된다. 또한 상기 X2에서 m은 일반식(I)에서와 같고 R5는 수소 또는 아미디노기이며 R1과 R5중 최소한 하나는 수소이다.
  2. 제1항에 있어서, 암모니아를 펩티드 에스테르(IV)와 반응시킴을 특징으로하는, R3가 카바밀인 일반식(I)의 펩티드 또는 그것의 염의 제조방법.
    여기에서 R1,R2,X2,Z1과 Z2는 일반식(I)과 같고, -OR4는 적합한 치환성 알콕시, 아르알콕시 또는 아릴옥시기이다.
  3. 제1항에 있어서, 펩티드 카르복실산(V) 또는 그것의 반응 유도체를 아민(VI)과 반응시키는 것을 특징으로 하는 일반식(I)의 펩티드 제조방법.
    여기에서 R1,R2,X2,Z1,Z2와 n은 일반식(I)과 같다.
  4. 제1항 내지 3항중 어느 한항에 있어서 R1이 아미노기인 제조방법.
  5. 제1항 내지 3항중 어느 한항에 있어서, X2가 D-아르기닐인 제조방법.
  6. 제1항 내지 5항중 어느 한항에 있어서 R2가 에틸렌인 제조방법.
  7. 제1,2항과 4항 내지 6항중 어느 한항에 있어서, R3가 카바밀인 제조방법.
  8. 제1항과 3항 내지 6항의 어느한항에 있어서 R3가 수소인 제조방법.
  9. 제1,3항 내지 6항과 8항의 어느 한항에 있어서 n이 1인 제조방법.
  10. 제1항 내지 9항중 어느 한항에 있어서 Z1과 Z2중 하나가 수소이며 다른 하나가 니트로 또는 플루오로인 제조방법.
  11. 제1항 내지 9항중 어느 한항에 있어서 Z1과 Z2중 하나가 수소이며 다른 하나가 4- 위치에 존재하는 제조방법.
  12. 제1항에 있어서, R1이 수소인 각각 상응한 일반식(I)의 펩티드를 아미드화시키는 것을 특징으로 하고, H2NC(:HN) Ty2·D-Arg·Gly·N(C2H5)·CH2 H2N(:HN)·Ty2·D-Arg · Gly·Et Phe(4NO2) · NH2와 H2NC(: HN) · Tyr · D-Arg · Gly · Et Phe(4F) ·NH2로 부터 선택된 펩티드 또는 그것의 염을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840002863A 1983-05-26 1984-05-25 약학적 유용 펩티드의 제조방법 KR850000467A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838314646A GB8314646D0 (en) 1983-05-26 1983-05-26 Pharmaceutical amides
GB8314646 1983-05-26

Publications (1)

Publication Number Publication Date
KR850000467A true KR850000467A (ko) 1985-02-27

Family

ID=10543432

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840002863A KR850000467A (ko) 1983-05-26 1984-05-25 약학적 유용 펩티드의 제조방법

Country Status (17)

Country Link
US (1) US4540682A (ko)
EP (1) EP0127154B1 (ko)
JP (1) JPS59231053A (ko)
KR (1) KR850000467A (ko)
AT (1) ATE57188T1 (ko)
AU (1) AU575324B2 (ko)
CA (1) CA1251898A (ko)
DE (1) DE3483338D1 (ko)
DK (1) DK258884A (ko)
ES (2) ES8606395A1 (ko)
FI (1) FI82254C (ko)
GB (1) GB8314646D0 (ko)
GR (1) GR81890B (ko)
HU (1) HU193569B (ko)
IL (1) IL71932A (ko)
NZ (1) NZ208283A (ko)
ZA (1) ZA844004B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622090D0 (en) * 1986-09-12 1986-10-22 Wellcome Found Pharmacologically active compounds
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6613508B1 (en) 1996-01-23 2003-09-02 Qiagen Genomics, Inc. Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
US6312893B1 (en) 1996-01-23 2001-11-06 Qiagen Genomics, Inc. Methods and compositions for determining the sequence of nucleic acid molecules
US6027890A (en) * 1996-01-23 2000-02-22 Rapigene, Inc. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
AU6990796A (en) * 1996-08-23 1998-03-06 Sederma Sa Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
US20100093643A1 (en) * 2006-08-17 2010-04-15 Irina Bobrova Cardioprotective compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178371A (en) * 1977-12-15 1979-12-11 Reckitt & Colman Products Limited Tetrapeptide derivatives
US4288432A (en) * 1979-06-12 1981-09-08 Richter Gedeon Vegyeszeti Gyar Rt. Novel enkephalin analogs and process for the preparation thereof
US4265808A (en) * 1979-12-17 1981-05-05 Eli Lilly And Company Pharmacologically active peptides
US4322339A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
EP0127154A2 (en) 1984-12-05
ATE57188T1 (de) 1990-10-15
EP0127154A3 (en) 1987-05-06
GB8314646D0 (en) 1983-06-29
GR81890B (ko) 1984-12-12
NZ208283A (en) 1988-07-28
AU2870184A (en) 1984-11-29
ES8606395A1 (es) 1986-04-01
CA1251898A (en) 1989-03-28
IL71932A (en) 1987-10-20
ES8604991A1 (es) 1986-03-01
DK258884D0 (da) 1984-05-25
EP0127154B1 (en) 1990-10-03
US4540682A (en) 1985-09-10
IL71932A0 (en) 1984-09-30
ES545189A0 (es) 1986-03-01
FI842104A (fi) 1984-11-27
HU193569B (en) 1987-10-28
DE3483338D1 (de) 1990-11-08
HUT34764A (en) 1985-04-28
FI842104A0 (fi) 1984-05-25
AU575324B2 (en) 1988-07-28
FI82254B (fi) 1990-10-31
ES532813A0 (es) 1986-04-01
ZA844004B (en) 1986-01-29
FI82254C (fi) 1991-02-11
DK258884A (da) 1984-11-27
JPS59231053A (ja) 1984-12-25

Similar Documents

Publication Publication Date Title
KR850000467A (ko) 약학적 유용 펩티드의 제조방법
KR850004594A (ko) 펩타이드의 제조방법
EP0236987A3 (en) Chemically modified protein and production thereof
PT99677A (pt) Processo de preparacao de um polipeptido que se liga a gpiia-iiib de vectores de composicoes de anticorpos e processo de ligacao de celulas a um substrato
KR860000314A (ko) 펩타이드의 제조방법
KR840009069A (ko) 향정신성 펩티드류의 제조 방법
ATE36704T1 (de) Verfahren zur herstellung von (hydrocarbylthio)- cyclischen aminen.
EP0097298A3 (en) Polyamines, process for producing polyamines and their use in the production of polyurethanes
KR880003965A (ko) 이노소오스 유도체, 그의 제조방법 및 용도
ATE169042T1 (de) Verfahren zur herstellung von biuretgruppen- haltigen polyisocyanaten
DE69219211D1 (de) Hydrochlorierung katalytisches System und Verfahren zur Herstellung von Vinylchlorid aus Acetylen und Chlorwasserstoff, in Gegenwart dieses katalytischen Systems
FI953874A (fi) Menetelmä keteenidimeerien valmistamiseksi
GB1516515A (en) Process for the preparation of insulin analogues and derivatives thereof
DE50110667D1 (de) Verfahren zur Herstellung von Organosilylalkylpolysulfanen
KR850004791A (ko) 프로테아제 억제제의 제조방법
JPS6431752A (en) Amide derivative and skin external preparation containing said derivative
DK0876610T3 (da) Fremgangsmåde og anvendelse af polypeptid i sædcelle-æg-binding til at foröge eller mindske fertilitet
GB1427902A (en) Process for the preparation of 1,3-dichloro-butene-2
KR900007781A (ko) 에틸렌디아민류의 제법
ES8601099A1 (es) Procedimiento para la preparacion de nuevos derivados de n-(metoxifenacil)-amina
ATE20048T1 (de) Verfahren zur herstellung von 1,1-dihydroperfluoralkanolen.
JPS6416792A (en) Guanidine related compound containing tetraphenylborate ion, its production and use thereof in peptide synthesis
EP0307662A3 (en) Enkephalin analogs
EP0106282A3 (en) Production of caerulein intermediate
DE68908477T3 (de) "Verfahren zur Herstellung von Selegilin-hydrochlorid"

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application